HEAL vs. IDNA
HEAL (Global X HealthTech ETF) and IDNA (iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund) are both Health & Biotech Equities funds - HEAL tracks the Global X HealthTech Index while IDNA tracks the NYSE FactSet Global Genomics and Immuno Biopharma Index. Both are passively managed. Over the past 5 years, HEAL returned -14.74%/yr vs -8.07%/yr for IDNA. A 0.71 correlation means they provide meaningful diversification when combined. HEAL charges 0.50%/yr vs 0.47%/yr for IDNA.
Performance
HEAL vs. IDNA - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, HEAL achieves a -11.69% return, which is significantly lower than IDNA's 17.72% return.
HEAL
- 1D
- -1.35%
- 1M
- 3.99%
- YTD
- -11.69%
- 6M
- -14.62%
- 1Y
- -19.29%
- 3Y*
- -8.58%
- 5Y*
- -14.74%
- 10Y*
- —
IDNA
- 1D
- 0.46%
- 1M
- 4.69%
- YTD
- 17.72%
- 6M
- 14.99%
- 1Y
- 51.77%
- 3Y*
- 10.60%
- 5Y*
- -8.07%
- 10Y*
- —
HEAL vs. IDNA - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
HEAL Global X HealthTech ETF | -11.69% | -0.62% | -2.87% | -12.61% | -29.99% | -14.21% | 16.89% |
IDNA iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund | 17.72% | 17.26% | -0.72% | -7.63% | -42.28% | -3.98% | 21.46% |
Correlation
The correlation between HEAL and IDNA is 0.58, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.58 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.61 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.70 |
Correlation (All Time) Calculated using the full available price history since Jul 30, 2020 | 0.71 |
The correlation between HEAL and IDNA shifts across timeframes, from 0.58 (1 year) to 0.71 (all time), reflecting how their relationship changes across market environments.
HEAL vs. IDNA - Sectors Allocation Comparison
Sectors
HEAL
IDNA
Healthcare
Technology
-
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Financial Services
-
-
Industrials
-
Real Estate
-
-
Utilities
-
-
Healthcare
HEAL
IDNA
Technology
HEAL
IDNA
-
Basic Materials
HEAL
-
IDNA
-
Communication Services
HEAL
-
IDNA
-
Consumer Cyclical
HEAL
-
IDNA
-
Consumer Defensive
HEAL
-
IDNA
-
Energy
HEAL
-
IDNA
-
Financial Services
HEAL
-
IDNA
-
Industrials
HEAL
-
IDNA
Real Estate
HEAL
-
IDNA
-
Utilities
HEAL
-
IDNA
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
HEAL vs. IDNA — Risk / Return Rank
HEAL
IDNA
HEAL vs. IDNA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Global X HealthTech ETF (HEAL) and iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| HEAL | IDNA | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.95 | ||
| Sortino ratioReturn per unit of downside risk | -4.09 | ||
| Omega ratioGain probability vs. loss probability | 0.87 | 1.33 | -0.46 |
| Calmar ratioReturn relative to maximum drawdown | -0.63 | 4.88 | -5.51 |
| Martin ratioReturn relative to average drawdown | -1.21 | 13.60 | -14.82 |
Loading charts...
Drawdowns
HEAL vs. IDNA - Drawdown Comparison
The maximum HEAL drawdown since its inception was -65.76%, roughly equal to the maximum IDNA drawdown of -68.26%. Use the drawdown chart below to compare losses from any high point for HEAL and IDNA.
Loading charts...
Drawdown Indicators
| HEAL | IDNA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -65.76% | -68.26% | +2.50% |
Max Drawdown (1Y)Largest decline over 1 year | -30.71% | -10.66% | -20.05% |
Max Drawdown (3Y)Largest decline over 3 years | -35.78% | -29.46% | -6.32% |
Max Drawdown (5Y)Largest decline over 5 years | -60.36% | -68.26% | +7.90% |
Current DrawdownCurrent decline from peak | -61.88% | -41.96% | -19.92% |
Average DrawdownAverage peak-to-trough decline | -43.19% | -36.28% | -6.91% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 15.92% | 3.82% | +12.10% |
Volatility
HEAL vs. IDNA - Volatility Comparison
Global X HealthTech ETF (HEAL) and iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA) have volatilities of 7.15% and 7.25%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| HEAL | IDNA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.15% | 7.25% | -0.10% |
Volatility (6M)Calculated over the trailing 6-month period | 16.56% | 18.40% | -1.84% |
Volatility (1Y)Calculated over the trailing 1-year period | 22.42% | 24.97% | -2.55% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 26.46% | 28.46% | -2.00% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 26.28% | 29.52% | -3.24% |
HEAL vs. IDNA - Expense Ratio Comparison
HEAL has a 0.50% expense ratio, which is higher than IDNA's 0.47% expense ratio.
Dividends
HEAL vs. IDNA - Dividend Comparison
HEAL's dividend yield for the trailing twelve months is around 0.37%, less than IDNA's 0.91% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
HEAL Global X HealthTech ETF | 0.37% | 0.33% | 0.00% | 0.00% | 0.00% | 0.00% | 0.03% | 0.00% |
IDNA iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund | 0.91% | 1.18% | 0.98% | 1.04% | 0.54% | 0.70% | 0.26% | 0.80% |
Frequently Asked Questions
HEAL and IDNA have a correlation of 0.58, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
IDNA has higher volatility (7.25%) compared to HEAL (7.15%). In terms of maximum drawdown, HEAL dropped -65.76% vs IDNA's -68.26%.
On 5-year performance, IDNA leads with -8.07% vs -14.74% for HEAL. On fees, IDNA is cheaper at 0.47% per year. On volatility, HEAL has been the lower-risk option at 7.15%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 5-year period, IDNA has performed better with a -8.07% return vs -14.74%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
IDNA is cheaper with a 0.47% expense ratio, compared with 0.50% for HEAL.
IDNA has the higher dividend yield at 0.91%, compared with 0.37% for HEAL.
HEAL tracks Global X HealthTech Index, while IDNA tracks NYSE FactSet Global Genomics and Immuno Biopharma Index. They also come from different issuers: Global X and iShares. Their fees differ too: 0.50% for HEAL and 0.47% for IDNA.
IDNA currently has the higher Sharpe Ratio (2.09 vs -0.87), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for HEAL and IDNA
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer